Company Details
Shaanxi YXchuang Biotechnology Co., Ltd
It has been demonstrated to increase the release of, and produces sustained increases in plasma levels of several hormones including hormone and , but without affecting cortisol levels.
3. MK-677 is currently under development as a potential treatment for reduced levels of these hormones which make it a promising therapy for the treatment of frailty in the elderly.
4. MK-677 also alters metabolism of body fat and so may have application in the treatment of obesity